Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry. 2004;161(9):1709-11. DOI: 10.1176/appi.ajp.161.9.1709. PubMed PMID: 15337666.

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

Conley RR, Love RC, Kelly DL, Bartko JJ. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. AJP. 1999;156(6):863-8. DOI: 10.1176/ajp.156.6.863. PubMed PMID: 10360124.

Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine.

Werneck AP, Hallak JC, Nakano E, Elkis H. Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine. Psychiatry Res. 2011;188(3):315-9. DOI: 10.1016/j.psychres.2011.04.004. PubMed PMID: 21596442.

Delirious mania: clinical features and treatment response.

Karmacharya R, England ML, Ongür D. Delirious mania: clinical features and treatment response. J Affect Disord. 2008;109(3):312-6. DOI: 10.1016/j.jad.2007.12.001. PubMed PMID: 18191210.

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.

Lane H-Y, Huang C-L, Wu P-L, Liu Y-C, Chang Y-C, Lin P-Y, et al. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biol Psychiatry. 2006;60(6):645-9. DOI: 10.1016/j.biopsych.2006.04.005. PubMed PMID: 16780811.

Effects of typical and atypical antipsychotics on human glycine transporters.

Williams JB, Mallorga PJ, Conn PJ, Pettibone DJ, Sur C. Effects of typical and atypical antipsychotics on human glycine transporters. Schizophr Res. 2004;71(1):103-12. DOI: 10.1016/j.schres.2004.01.013. PubMed PMID: 15374578.

Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.

Veerman SRT, Schulte PFJ, Begemann MJH, Engelsbel F, de Haan L. Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis. Pharmacopsychiatry. 2014;47(6):185-94. DOI: 10.1055/s-0034-1383656. PubMed PMID: 25002291.

Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes.

Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M. Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Br J Pharmacol. 2012;165(5):1543-55. DOI: 10.1111/j.1476-5381.2011.01638.x. PubMed PMID: 21880034.

Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.

Schwieler L, Linderholm KR, Nilsson-Todd LK, Erhardt S, Engberg G. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area. Life Sci. 2008;83(5-6):170-5. DOI: 10.1016/j.lfs.2008.05.014. PubMed PMID: 18590745.

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158(3):360-9. DOI: 10.1176/appi.ajp.158.3.360. PubMed PMID: 11229973.